The synthesis of novel C2-symmetric P,N-chelation ruthenocene ligands and their application in palladium-catalyzed asymmetric allylic substitution

Novel air-stable C₂-symmetric tetrasubstituted ruthenocene-based ligands were readily synthesized and used for palladium-catalyzed asymmetric allylic substitution showing excellent enantioselectivity and high catalytic activity.     

π -Type and σ -type cation- π complexes of atomic cations

MP2/6-31+G* calculations were performed on the cation- complexes of ethylene, cyclobutadiene and benzene with a number of atomic cations. It was found that except B⁺ all the atomic cations form -type cation- complexes with ethylene. On the other hand, with cyclobutadiene Li⁺, N⁺, Na⁺, P⁺ and K⁺ form -type complexes, whereas H⁺, F⁺, and Cl⁺ form covalent -type complexes. With benzene Li⁺, B⁺, Na⁺, Al⁺, and K⁺ form -type complexes whereas H⁺, F⁺, and Cl⁺ form -type complexes. It was concluded that the driving force to form the -type complex is chemical bonding, and that for metal cations to form -type complexes is non-covalent interaction.     

Reactions of RSe− (R = Me,Ph) Groups in [RSeFe(CO)4I and [RSeCr(CO)5−]

The anionic [MeSeFe(CO)₄] and [MeSeCr(CO)₅] complexes were synthesized by reaction of [PPN][HFe(CO)₄] and [PPN][HCr(CO)₅] with MeSeSeMe respectively via nucleophilic cleavage of the Se-Se bond. The ease of cleavage of the Se-Se bond follows the nucleophilic strength of metal-hydride complexes. Methylation of [RSeCr(CO)₅^?] by the soft alkylating agent MeI resulted in the formation of neutral (MeSeMe)Cr(CO)₅ in THF at 0°C. In contrast, the [ICr(CO)₅^?] was isolated at ambient temperature. Reaction of [MeSeFe(CO)₄^?] or [MeSeCr(CO)₅^?] with HBF₄ yielded (CO)₃Fc(μ-SeMe)₂Fe(CO)₃ dimer and anionic [(CO )₅Cr (μ-SeMe)Cr(CO)₅^?] respectively, and no neutral (HSeMe)Fe(CO)₄ and (HSeMe)Cr(CO)₅ were detected spectrally (IR) even at low temperature. Reaction of NOBF₄ or [Ph₃C][BF₄] and [MeSeCr(CO)₅^?] resulted in the neutral monodentate (MeSeSeMe)Cr(CO)₅ complex. Addition of 1 equiv CpFe(CO)₂I to 2 equiv [MeSeCr(CO)₅^?] gave CpFe(CO)₂(SeMe) and the anionic [(CO)₅Cr(μ-SeMe)Cr(CO)₅^?] in THF at ambient temperature.     

Polyamide thin film composite membrane prepared from m-phenylenediamine and m-phenylenediamine-5-sulfonic acid

Thin film composite (TFC) membranes based polyamide were prepared with m-phenylenediamine (MPD), m-phenylenediamine-5-sulfonic acid (SMPD) and trimesoyl chloride (TMC) through interfacial polymerization technique on the polysulphone supporting film. The membranes were characterized using permeation experiments with salt water, attenuated total reflectance infrared (ATR-IR) and X-ray photoelectronic spectroscopy (XPS) as well as scanning electronic microscopy (SEM). This study has shown that the active layer of TFC membrane is aromatic polyamide, including sulfuric acid function group (-SO₃H) according to the result of ATR-IR and XPS. The NaCl rejection of RO membranes decreased and the flux increased when W_SMPD/W_MPD increased from 0 to 1, and the linear part with pendant -COOH in membrane barrier layer increased with the increase of SMPD content, but the surface of membrane becoming smoother and smoother with the increase of SMPD content. So the membranes performance mainly was determined by chemical structure in their barrier layer.     

ZnS胶体溶液中某些无机盐光化学过程中产生的阴离子自由基的ESR研究

本文用自旋捕捉与ＥＳＲ技术相结合的方法研究了ＺｎＳ胶体溶液中某些无机盐光化学过程中产生的无机阴离子自由基，并对自由基产生的机理进行了讨论     

脂肪族酰胺二元醇的合成与表征

以ＤＬ－乳酸、ε己内酯及乙二胺和己二胺为原料合成了四种结构的脂肪族酰胺二元醇，并用ＩＲ，＾１ＨＮＭＲ，ＤＳＣ对酰胺二元醇的结构进行了表征。     

Reaction of Tetracopper(I)-Phosphonitocavitand with PhSeSiMe3: Synthesis and Structure of a Polyanionic Cluster [pyH]6[(CuCl)9(μ3-SePh)5(μ4-SePh)]

Treatment of tetracopper(I)-phosphonitocavitand [1·Cu₄(μ-Cl)₄(μ₄-Cl)] (2) (1 = tetraphosphonitocavitand [rccc-2,8,14,20-tetrakis-(iso-butyl)-phosphonitocavitand (C₄₄H₄₈O₈P₄Ph₄)]) with PhSeSiMe₃ in THF at low temperature afforded a novel polyanionic cluster [pyH]₆[(CuCl)₉(μ₃-SePh)₅(μ₄-SePh)] (4) as a major product along with a new tetracopper(I)-phosphonitocavitand (3) with a centered μ₃-Cl. Molecular structure of anionic cluster in 4 consists of six PhSe⁻ bridging ligands containing five μ₃-SePh and one exceptional μ₄-SePh bridging nine copper atoms, of which eight copper atoms have trigonal coordination geometry and the other has distorted tetrahedral geometry. Dedicated to Professor Han-Qin Liu on the occasion of his 70th birthday.     

Study on the Silylation of Aromatic Hydrocarbons. The Trimethylsilylation of Naphthalene

Direct trimethylsilylation of naphthalene under certain condition has been found to afford substitution as well as addition products: 1-and 2-trimethylsilylnaphtalene (I, II), 1-trimethylsilyl-1,4-dihydronaphthalene (III), trans-1,2-bis(trimethylsilyl)-1,2-dihydronaphthalene (IV-a) and its isomer (IV-b), and 1,2,4-tris(trimethylsilyl)-1,2-dihydronaphthalene (V). The configuration has been determined by nmr spectroscopy, and the possible reaction path was proposed.     

扩张床吸附技术

扩张床是流化床的一种特例。它具有流化床的特点,能处理含悬浮颗粒的液体。又具有固定床的优点,流动成活塞流;返混程度低,分离效率高。作为蛋白质的初步分离方法,它能取代固液分离、浓缩和初步纯化等三步操作。具有提高收率、降低投资费用、缩短操作时间等优点,成为生物工程下游过程的研究热点。本文综述了近年来扩张床吸附技术的发展。包括：1、原理：床层的分层稳定性、吸附剂和吸附柱;2、操作：吸附、洗涤、洗脱和再生4个步骤;3、流动动力学特性：床层扩展特征和停留时间分布;4．在蛋白质纯化中的应用。     

Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine

Precision medicine has been strongly promoted in recent years. It is used in clinical management for classifying diseases at the molecular level and for selecting the most appropriate drugs or treatments to maximize efficacy and minimize adverse effects. In precision medicine, an in-depth molecular understanding of diseases is of great importance. Therefore, in the last few years, much attention has been given to translating data generated at the molecular level into clinically relevant information. However, current developments in this field lack orderly implementation. For example, high-quality chemical research is not well integrated into clinical practice, especially in the early phase, leading to a lack of understanding in the clinic of the chemistry underlying diseases. In recent years, mass spectrometry (MS) has enabled significant innovations and advances in chemical research. As reported, this technique has shown promise in chemical mapping and profiling for answering “what”, “where”, “how many” and “whose” chemicals underlie the clinical phenotypes, which are assessed by biochemical profiling, MS imaging, molecular targeting and probing, biomarker grading disease classification, etc. These features can potentially enhance the precision of disease diagnosis, monitoring and treatment and thus further transform medicine. For instance, comprehensive MS-based biochemical profiling of ovarian tumors was performed, and the results revealed a number of molecular insights into the pathways and processes that drive ovarian cancer biology and the ways that these pathways are altered in correspondence with clinical phenotypes. Another study demonstrated that quantitative biomarker mapping can be predictive of responses to immunotherapy and of survival in the supposedly homogeneous group of breast cancer patients, allowing for stratification of patients. In this context, our article attempts to provide an overview of MS-based chemical mapping and profiling, and a perspective on their clinical utility to improve the molecular understanding of diseases for advancing precision medicine.

An overview of MS-based chemical mapping and profiling, indicating its contributions to the molecular understanding of diseases in precision medicine by answering "what", "where", "how many" and "whose” chemicals underlying clinical phenotypes.